Financhill
Sell
38

FOLD Quote, Financials, Valuation and Earnings

Last price:
$9.00
Seasonality move :
2.68%
Day range:
$8.85 - $9.12
52-week range:
$8.55 - $12.65
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
5.25x
P/B ratio:
14.44x
Volume:
2M
Avg. volume:
2.4M
1-year change:
-20.56%
Market cap:
$2.8B
Revenue:
$528.3M
EPS (TTM):
-$0.18

Amicus Therapeutics SEC Filings

Company Filed Form Type Description
FOLD
Amicus Therapeutics
05/09/2024 10-Q 10-Q filing on 05/09/2024 View Form
FOLD
Amicus Therapeutics
11/08/2023 10-Q 10-Q filing on 11/08/2023 View Form
FOLD
Amicus Therapeutics
08/08/2023 10-Q 10-Q filing on 08/08/2023 View Form
FOLD
Amicus Therapeutics
05/10/2023 10-Q 10-Q filing on 05/10/2023 View Form
FOLD
Amicus Therapeutics
11/07/2022 10-Q 10-Q filing on 11/07/2022 View Form
FOLD
Amicus Therapeutics
08/04/2022 10-Q 10-Q filing on 08/04/2022 View Form
FOLD
Amicus Therapeutics
05/10/2022 10-Q 10-Q filing on 05/10/2022 View Form
FOLD
Amicus Therapeutics
11/09/2021 10-Q 10-Q filing on 11/09/2021 View Form
FOLD
Amicus Therapeutics
08/05/2021 10-Q 10-Q filing on 08/05/2021 View Form
FOLD
Amicus Therapeutics
05/10/2021 10-Q 10-Q filing on 05/10/2021 View Form
FOLD
Amicus Therapeutics
11/05/2020 10-Q 10-Q filing on 11/05/2020 View Form
FOLD
Amicus Therapeutics
08/10/2020 10-Q 10-Q filing on 08/10/2020 View Form
FOLD
Amicus Therapeutics
05/07/2020 10-Q 10-Q filing on 05/07/2020 View Form
FOLD
Amicus Therapeutics
03/02/2020 10-K 10-K filing on 03/02/2020 View Form
FOLD
Amicus Therapeutics
11/12/2019 10-Q 10-Q filing on 11/12/2019 View Form
FOLD
Amicus Therapeutics
08/08/2019 10-Q 10-Q filing on 08/08/2019 View Form
FOLD
Amicus Therapeutics
05/09/2019 10-Q 10-Q filing on 05/09/2019 View Form
FOLD
Amicus Therapeutics
02/28/2019 10-K 10-K filing on 02/28/2019 View Form
FOLD
Amicus Therapeutics
11/05/2018 10-Q 10-Q filing on 11/05/2018 View Form
FOLD
Amicus Therapeutics
08/07/2018 10-Q 10-Q filing on 08/07/2018 View Form
FOLD
Amicus Therapeutics
05/09/2018 10-Q 10-Q filing on 05/09/2018 View Form
FOLD
Amicus Therapeutics
03/01/2018 10-K 10-K filing on 03/01/2018 View Form
FOLD
Amicus Therapeutics
11/08/2017 10-Q 10-Q filing on 11/08/2017 View Form
FOLD
Amicus Therapeutics
08/07/2017 10-Q 10-Q filing on 08/07/2017 View Form
FOLD
Amicus Therapeutics
05/09/2017 10-Q 10-Q filing on 05/09/2017 View Form
FOLD
Amicus Therapeutics
03/03/2017 10-K 10-K filing on 03/03/2017 View Form
FOLD
Amicus Therapeutics
03/01/2017 10-K 10-K filing on 03/01/2017 View Form
FOLD
Amicus Therapeutics
11/07/2016 10-Q 10-Q filing on 11/07/2016 View Form
FOLD
Amicus Therapeutics
08/09/2016 10-Q 10-Q filing on 08/09/2016 View Form
FOLD
Amicus Therapeutics
05/03/2016 10-Q 10-Q filing on 05/03/2016 View Form
FOLD
Amicus Therapeutics
02/29/2016 10-K 10-K filing on 02/29/2016 View Form
FOLD
Amicus Therapeutics
11/04/2015 10-Q 10-Q filing on 11/04/2015 View Form
FOLD
Amicus Therapeutics
08/05/2015 10-Q 10-Q filing on 08/05/2015 View Form
FOLD
Amicus Therapeutics
05/05/2015 10-Q 10-Q filing on 05/05/2015 View Form

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is CyberArk The Next Big Cybersecurity Stock?
Is CyberArk The Next Big Cybersecurity Stock?

CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…

Is the Market Going to Go Lower?
Is the Market Going to Go Lower?

The last month has been extremely difficult for the stock…

2 Dividend Stocks to Buy in a Recession
2 Dividend Stocks to Buy in a Recession

While many economists and investors initially expected 2025 to be…

Stock Ideas

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 41x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Buy
52
RGC alert for Mar 18

Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.

Buy
63
EXOD alert for Mar 18

Exodus Movement [EXOD] is down 3.96% over the past day.

Sell
45
MNPR alert for Mar 18

Monopar Therapeutics [MNPR] is up 0.93% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock